|
Journal of Child and Adolescent Psychopharmacology
Concomitant Use of Atomoxetine and OROS®-Methylphenidate in a 10-Year-Old Child Suffering from Attention-Deficit/Hperactivity Disorder with Comorbid Bipolar Disorder and Tourette Syndrome.
To cite this article:
Sol Jaworowski, Fortu Benarroch, Varda Gross-Tsur.
Journal of Child and Adolescent Psychopharmacology.
2006,
16(3): 365-370.
doi:10.1089/cap.2006.16.365.
Sol Jaworowski, MBBS, FRANZCPShaare Zedek Medical Centre, Jerusalem, Israel. Fortu Benarroch, M.D.Shaare Zedek Medical Centre, Jerusalem, Israel. Varda Gross-Tsur, M.D.Shaare Zedek Medical Centre, Jerusalem, Israel. Atomoxetine and OROS® methylphenidate were successfully used concomitantly in a 10- year-old boy suffering from attention-deficit/hyperactivity disorder (ADHD) with comorbid bipolar disorder and Tourette syndrome (TS). The child received valproic acid, clonidine, and ziprasidone concurrently. Because possible side effects of pharmacological treatment for one diagnosis may exacerbate a comorbid condition, contingent management strategies, when using polypharmacy, are mandated.
|
|
TOC Alert
CiteULike
Delicious
Digg This
Facebook
Newsvine